Quarterly report pursuant to Section 13 or 15(d)

Other Balance Sheet Items (Tables)

v3.23.2
Other Balance Sheet Items (Tables)
 9 Months Ended
Jun. 30, 2023
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]  
Schedule of Cash and Cash Equivalents
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
June 30, 2023 September 30, 2022
(in thousands)
Cash and cash equivalents $ 35,007  $ 40,658 
Restricted cash 56,686  96,137 
Cash, cash equivalents, and restricted cash $ 91,693  $ 136,795 
Schedule of Restrictions on Cash and Cash Equivalents
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
June 30, 2023 September 30, 2022
(in thousands)
Cash and cash equivalents $ 35,007  $ 40,658 
Restricted cash 56,686  96,137 
Cash, cash equivalents, and restricted cash $ 91,693  $ 136,795 
Schedule of Supplementary Cash Flow Information
Table 10.2: Supplemental Disclosures of Cash Flow Information
For the Nine Months Ended
June 30, 2023 June 30, 2022
(in thousands)
Interest payments $ 59,580  $ 28,251 
Income tax payments $ 60,460  $ 64,057 
Schedule of Details of Accounts Receivable
Table 10.3: Details of Accounts Receivable, Net
June 30, 2023 September 30, 2022
(in thousands)
Billed and billable receivables $ 683,180  $ 723,979 
Unbilled receivables 120,097  91,404 
Allowance for credit losses (4,768) (8,273)
Accounts receivable, net $ 798,509  $ 807,110